Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Alexa Hansen is a partner in Covington’s San Francisco office practicing in the area of patent litigation and matters before the Patent Trial and Appeals Board, with an emphasis on pharmaceutical and biological patents. In addition to her litigation work, she also provides patent analysis for product acquisitions and financial transactions. Prior to law school, she worked as a medicinal chemist at Merck & Co. designing small molecule drugs. As a result of her research there, Ms. Hansen is a named inventor on three patents.

  • Representation of UCB in Hatch-Waxman litigation filed against 16 generic companies in the District of Delaware involving UCB’s Vimpat® product, used in the treatment of epilepsy and other CNS disorders. The Court’s opinion found the asserted claims infringed and not invalid.
  • Representation of Research Corporation Technologies, Inc., and licensees Harris FRC Corporation and UCB, as patent owner in two IPR proceedings, challenging the patent claiming Vimpat®, UCB’s anti-epileptic drug. The PTAB dismissed the first petition without instituting trial. As to the second petition, after a full trial, the PTAB found all claims in the patent not invalid.
  • Representation of leading pioneer pharmaceutical company in Hatch-Waxman patent litigation against several generic drug companies involving a drug indicated to reduce the risk of COPD exacerbations (D.N.J.)
  • Representation of University of Massachusetts and Carnegie Institute of Washington in litigation relating to intellectual property rights to RNA interference technologies. (Ali v. Carnegie Institution of Washington and University of Massachusetts (D. D.C. 2013)).
  • Represented Bristol-Myers Squibb in patent litigation in the District of New Jersey against Dr. Reddy’s Laboratories relating to IXEMPRA® Kit, an intravenous infusion treatment for metastatic or locally advanced breast cancer after failure of at least an anthracycline and a taxane, ending in a favorable result for BMS. (Bristol-Myers Squibb Company v. Dr. Reddy’s Laboratories Ltd., et al. (D.N.J.)).
  • Represented Merck & Co., Inc. and Roche Palo Alto LLC in patent litigation in the District of New Jersey against Sun Pharmaceutical Industries, Ltd. relating to Ganirelix Acetate Injection, which is one of the drugs used in women undergoing in vitro fertilization.
  • Represented Merck before the International Trade Commission, ending in a favorable result for Merck. (In re Certain Vaginal Ring Birth Control Devices (USITC)).
  • Represented Samsung Electronics Co., Ltd. in a patent infringement case involving semiconductor fabrication technologies and memory chip design. The parties agreed to a settlement after Ms. Hansen helped brief a successful summary judgment motion of noninfringement. (Advanced Micro Devices, Inc. et al. v. Samsung Electronics Co., Ltd., et al., CV-08-0986 SI, N.D. Cal.).
  • Advise clients on litigation strategy relating to pharmaceutical patent protection.
  • Counseled pharmaceutical companies concerning prospective acquisitions of intellectual property relating to pharmaceutical products.

Pro Bono

  • Representation of client on appeal to the Federal Circuit from proceedings before the Merit Systems Protection Board.
  • Represented family from Cambodia in asylum proceedings before the Ninth Circuit and Immigration court.
  • Represented lesbian from Mexico in asylum proceedings before the Immigration court.
  • Represented Plaintiff class in class action against City of Antioch for civil rights violations. (Williams, et al. v. City of Antioch, 08-CV-02301-SBA, N.D. Cal.).

Memberships and Affiliations

  • Leadership Development Committee - Association of Business Trial Lawyers, Member
  • American Bar Association, Member
    • Past Chapter Editor, Annual Review for the IP section
  • American Chemical Society, Member
  • American Association for the Advancement of Science, Member

Previous Experience

  • Merck & Co., Medicinal Chemist (2004-2006)
  • Part of three person 2007-2008 National Champion Team, Saul Lefkowitz Moot Court Competition